Advertisement

Obstetric Hemorrhage

  • Alejandra Garcia Fernandez
  • Mary Jane ReedEmail author
Chapter
  • 3 Downloads

Abstract

The majority of deliveries occur without complication under the care of an obstetrical team. Maternal hemorrhage remains the leading cause of maternal mortality worldwide resulting in 1 death every 7 min (Say et al. Lancet Glob Health 2:e323–33, 2014). In the US, maternal hemorrhage has increased in the past 20 years, but mortality from postpartum obstetric hemorrhage has decreased in the past 30 years. This is likely related to early recognition and improved management. In postpartum women, the signs and symptoms of blood loss often do not present until substantial bleeding has occurred (Pacagnella et al. PLoS One 8(6), 2013). Therefore, all personnel involved in the care of peripartum and postpartum women should be trained in early recognition and management of this complication to avoid morbidity and mortality in this population.

Keywords

Postpartum hemorrhage Pregnancy Blood loss Transfusion Uterine atony Lacerations Retained placenta Defects in coagulation Uterotonics Tranexamic acid Arterial ligation Arterial embolization Hysterectomy 

References

  1. 1.
    Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2:e323–33. https://www.sciencedirect.com/science/article/pii/S2214109X1470227X CrossRefGoogle Scholar
  2. 2.
    Pacagnella RC, Souza JP, Durocher J, Perel P, Blum J, Winikoff B, et al. A systematic review of the relationship between blood loss and clinical signs. PLoS One. 2013;8(6)  https://doi.org/10.1371/annotation/4db90e4b-ae29-4931-9049-3ef5e5c9eeee. published erratum appears
  3. 3.
    Menard MK, Main EK, Currigan SM. Executive summary of the revitalize initiative: standardizing obstetric date definitions. Obstet Gynecol. 2014;124:150–3. https://journals.lww.com/greenjournal/fulltext/2014/07000/Executive_Summary_of_the_reVITALize_Initiative_.21.aspx CrossRefGoogle Scholar
  4. 4.
    Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample deliveries. Anesth Analg. 2010;110:1368–73. https://journals.lww.com/anesthesia-analgesia/fulltext/2010/05000/The_Epidemiology_of_Postpartum_Hemorrhage_in_a.21.aspx CrossRefGoogle Scholar
  5. 5.
    Bateman BT, Tsen LC, Liu J, Butwick AJ, Huybrechts KF. Patterns of second-line uterotonic use in a large sample of hospitalizations for childbirth in the United States: 2007-2011. Anesth Analg. 2014;119:1344–9. https://journals.lww.com/anesthesia-analgesia/fulltext/2014/12000/Patterns_of_Second_Line_Uterotonic_Use_in_a_Large.21.aspx CrossRefGoogle Scholar
  6. 6.
    Patacchiola F, D’ Alfonso A, Di Fonso A, Di Febbo G, Kaliakoudas D, Carta G. Intrauterine balloon tamponade as management of postpartum hemorrhage and prevention of hemorrhage related to low-lying placenta. Clin Exp Obstet Gynecol 2012;39:498–499.Google Scholar
  7. 7.
    B-Lynch C, Coker A, Lawal AH, Abu J, Cowen MJ. The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. Br J Obstet Gynaecol. 1997;104:372–5.  https://doi.org/10.1111/j.1471-0528.1997.tb11471.x.CrossRefPubMedGoogle Scholar
  8. 8.
    Shields LE, Smalarz K, Reffigee L, Mugg S, Burdumy TJ, Propst M. Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products. Am J Obstet Gynecol. 2011;205:368.e1–8. https://www.sciencedirect.com/science/article/pii/S0002937811008325 CrossRefGoogle Scholar
  9. 9.
    Shields LE, Weisner S, Fulton J, Pelletreau B. Comprehensive maternal hemorrhage protocols reduce the use of blood products and improved patients safety. Am J Obstet Gynecol. 2015;212:272–80. https://www.sciencedirect.com/science/article/pii/S0002937814006942 CrossRefGoogle Scholar
  10. 10.
    Shields LE, Goffman D, Caughey AB, et al. Committee on practice bulletins-obstetrics. Am College Obstet Gynecol. 2017;130:183.Google Scholar
  11. 11.
    Lyndon A, Lagrew D, Shields L, Main E, Cape V, editors. Improving health care response to obstetric hemorrhage version 2.0. A California quality improvement toolkit. Stanford, CA: California Maternal Quality Care Collaborative; 2015. https://www.cmqcc.org/resources-tool-kits/toolkits/ob-hemorrhage-toolkit Google Scholar
  12. 12.
    O’ Leary JL, O’ Leary JA. Uterine artery ligation in the control of intractable postpartum hemorrhage. Am J Obstet Gynecol. 1966;94:920–4. https://www.sciencedirect.com/science/article/pii/0002937866900263 CrossRefGoogle Scholar
  13. 13.
    O’ Leary JL, O’ Leary JA. Uterine artery ligation for control of postcesarean section hemorrhage. Am J Obstet Gynecol. 1974;43:849–53. https://journals.lww.com/greenjournal/Abstract/1974/06000/Uterine_Artery_Ligation_for_Control_of.9.aspx Google Scholar
  14. 14.
    Likis FE, Sathe NA, Morgans AK, Hartmann KE, Young JL, Carlson-Bremer D, et al. Management of postpartum hemorrhage. Comparative effectiveness Review No 151. AHRQ Publication No. 15-EHC013-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2015. (Systematic review). https://effectivehealthcare.ahrq.gov/topics/hemorrhage-postpartum/research/ Google Scholar
  15. 15.
    Kayem G, Kurinczuk JJ, Alfirevic Z, Spark P, Brocklehurst P, Knight M. Specific second-line therapies for postpartum haemorrhage: a national cohort study. BJOG. 2011;117:14–20.  https://doi.org/10.1111/j.1471-0528.2011.02921.x.CrossRefGoogle Scholar
  16. 16.
    WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017;389(10084):2105–16.  https://doi.org/10.1016/S0140-6736(17)30638-4.CrossRefGoogle Scholar
  17. 17.
    Treml AB, Gorlin JB, Dutton RP, Scavone BM. Massive transfusion protocols: a survey of academic medical centers in the United States. Anesth Analg. 2017;124:277–81.CrossRefGoogle Scholar
  18. 18.
    Laas E, Deis S, Haddad B, Kayem G. Comparison of the rate of maternal complications of nifedipine and nicardipine in cases of preterm labor: historical study on two consecutive periods [French]. J Gynecol Obstet Biol Reprod (Paris). 2012;41:631–7.Google Scholar
  19. 19.
    Yoong W, Ridout A, Memtsa M, Stavroulis A, Aref-Adib M, Ramsay-Marcelle Z, et al. Application of uterine compression suture in association with intrauter- ine balloon tamponade (‘uterine sandwich’) for postpartum hemorrhage. Acta Obstet Gynecol Scand. 2012;91:147–51.CrossRefGoogle Scholar
  20. 20.
    Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, et al. Use of recombinant acti- vated factor VII in primary postpartum hemorrhage: the northern European registry 2000-2004. Obstet Gynecol. 2007;110:1270–8.CrossRefGoogle Scholar
  21. 21.
    Kaya B, Guralp O, Tuten A, Unal O, Celik MO, Dogan A. Which uterine sparing technique should be used for uterine atony during cesarean section? The Bakri balloon or the B-Lynch suture? Arch Gynecol Obstet. 2016;294:511–7.CrossRefGoogle Scholar
  22. 22.
    Zwart JJ, Dijk PD, van Roosmalen J. Peripartum hysterectomy and arterial embolization for major obstetric hemorrhage: a 2-year nationwide cohort study in the Netherlands. Am J Obstet Gynecol. 2010;202:150.e1–7.CrossRefGoogle Scholar
  23. 23.
    American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. Practice bulletin: no. 183: postpartum hemorrhage. Obstet Gynecol. 2017;130:e168–86.CrossRefGoogle Scholar
  24. 24.
    Morel O, Malartic C, Muhlstein J, Gayet E, Judin P, Soyer P, et al. Pelvic arterial ligations for severe post-partum hemorrhage: indications and techniques. J Visc Surg. 2011;148:e95–e102.CrossRefGoogle Scholar
  25. 25.
    Stensaeth KH, Sovik E, Haig INY, Skomedal E, Jorgensen A. Fluoroscopy-free resuscitative endovascular balloon occlusion of the aorta (REBOA) for controlling life threatening postpartum hemorrhage. PLoS One. 2017;12(3):e0174520.  https://doi.org/10.1371/journal.pone.0174520.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Ordonez CA, Manzano-Nunez R, Parra MW, et al. Prophylactic use of resuscitative endovascular balloon occlusion of the aorta in women with abnormal placentation: a systematic review, meta-analysis, and case series. J Trauma Acute Care Surg. 2018;84:809–18.CrossRefGoogle Scholar
  27. 27.
    Brenner M, Bulger EM, Perina DG, et al. Trauma Surg Acute Care Open. 2018;3:1–3.Google Scholar
  28. 28.
    Lester F, Stenson A, Meyer C, Morris JL, Vargas J, Miller S. Impact of the non-pneumatic Antishock garment on pelvic blood flow in healthy postpartum women. Am J Obstet Gynecol. 2011;204(5):e1–5.CrossRefGoogle Scholar
  29. 29.
    Miller S, Bergel EF, El Ayadi A, Gibbons L, Butrick EA, Magwali T, et al. Non-pneumatic anti-shock garment (NASG), a first-aid device to decrease maternal mortality from obstetric hemorrhage: a cluster randomized trial. PLoS One. 2013;8(10):e76477.CrossRefGoogle Scholar
  30. 30.
    Experience in the use of non-pneumatic anti-shock garment (NASG) in the management of postpartum haemorrhage with hypovolemic shock in the Fundación Valle Del Lili, Cali, Colombia. Reprod Health. 2017;14(1):58.  https://doi.org/10.1186/s12978-017-0325-2.
  31. 31.
    WHO Reproductive Health Library. WHO recommendation on the use of non-pneumatic anti-shock garments for the treatment of postpartum haemorrhage. The WHO Reproductive Health Library, Geneva: World Health Organization; 2012.Google Scholar
  32. 32.
    American College of Obstetricians and Gynecologists. Postpartum hemorrhage. Practice bulletin no. 183. Obstet Gynecol. 2017;130:e168–86.  https://doi.org/10.1097/AOG.0000000000002351.

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  1. 1.Critical Care Medicine FellowGeisinger Medical CenterDanvilleUSA
  2. 2.Critical Care MedicineGeisinger Medical CenterDanvilleUSA

Personalised recommendations